Ceftin and Abilify drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ceftin (cefuroxime axetil) and Abilify (aripiprazole). Common drug interactions include type 2 diabetes mellitus among females.

The phase IV clinical study analyzes what interactions people have when they take Ceftin and Abilify. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Ceftin?

Ceftin has active ingredients of cefuroxime axetil. It is often used in sinusitis. eHealthMe is studying from 4,333 Ceftin users. Check the latest studies of Ceftin.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,454 Abilify users. Check the latest studies of Abilify.



On Jul, 24, 2026

18 people who take Ceftin and Abilify together, and have interactions are studied.

Ceftin and Abilify drug interactions.

What are the common drug interactions of Ceftin and Abilify, by gender? *:

female:

  1. Type 2 diabetes mellitus
  2. Dizziness
  3. Presbyopia (a condition in which the lens of the eye loses its ability to focus, making it difficult to see objects up close)
  4. Pyrexia (fever)
  5. Restless legs syndrome (a powerful urge to move your legs)
  6. Schizoaffective disorder (a mental disorder characterized by disordered thought)
  7. Tendonitis (a condition that causes pain and swelling of tendons)
  8. Vaginal infection
  9. Otitis media (inflammation of the middle ear)
  10. Diabetes mellitus inadequate control

male:

n/a

What are the common drug interactions of Ceftin and Abilify, by age (0-1 to 60+)? *:

0-1:

  1. Cerebral haemorrhage neonatal (bleeding in brain of baby of less than 1 month age)
  2. Mitral valve incompetence (inefficient heart valve)
  3. Neonatal respiratory distress syndrome (a serious medical condition where a newborn baby's lungs cannot provide their body with enough oxygen)
  4. Pulmonary artery stenosis congenital (congenital -narrowing (stenosis) that occurs in the lung artery)
  5. Right atrial dilatation (enlargement of the right atrium chamber of heart)
  6. Right ventricular hypertrophy (right ventricular enlargement)
  7. Tricuspid valve incompetence (inefficient heart valve)

2-9:

n/a

10-19:

n/a

20-29:

  1. Abdominal discomfort
  2. Abdominal pain
  3. Abdominal pain upper
  4. Biliary dyskinesia (motility disorder that affects the gallbladder and sphincter of oddi)
  5. Cholecystitis chronic (long lasting infection of gallbladder)
  6. Cholesterosis (abnormal deposition of cholesterol in tissues)
  7. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  8. Diarrhoea
  9. Faeces discoloured
  10. Hypokalaemia (low potassium)

30-39:

n/a

40-49:

  1. Blood glucose increased
  2. Chronic kidney disease
  3. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  4. Diabetes mellitus inadequate control
  5. Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus)
  6. Diabetic ulcer
  7. Type 1 diabetes mellitus

50-59:

  1. Neuropathy peripheral (surface nerve damage)
  2. Otitis externa (external ear infection)
  3. Presbyopia (a condition in which the lens of the eye loses its ability to focus, making it difficult to see objects up close)
  4. Pyrexia (fever)
  5. Restless legs syndrome (a powerful urge to move your legs)
  6. Schizoaffective disorder (a mental disorder characterized by disordered thought)
  7. Tendonitis (a condition that causes pain and swelling of tendons)
  8. Vaginal infection
  9. Otitis media (inflammation of the middle ear)
  10. Osteoarthritis (a joint disease caused by cartilage loss in a joint)

60+:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)

What are the existing conditions these people have? *

  1. Hyperlipidaemia (presence of excess lipids in the blood): 5 people, 27.78%
  2. Restless Leg Syndrome (a powerful urge to move your legs): 4 people, 22.22%
  3. Stress And Anxiety: 3 people, 16.67%
  4. Sleep Disorder: 3 people, 16.67%
  5. Back Pain: 3 people, 16.67%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 16.67%
  7. Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 3 people, 16.67%
  8. Pain: 3 people, 16.67%
  9. Nausea (feeling of having an urge to vomit): 2 people, 11.11%
  10. Fibromyalgia (a long-term condition which causes pain all over the body): 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Ceftin and Abilify?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ceftin and Abilify:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ceftin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Abilify:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ceftin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Abilify and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on cefuroxime axetil and aripiprazole (the active ingredients of Ceftin and Abilify, respectively), and Ceftin and Abilify (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: